Burning Rock Biotech

NMQ:BNR · US12233L2060

BiotechnologySmall

360

Medium confidence — indicative

Value61

Profit price94

Cash yield1

Owner Earnings Yield1

Dividend Yield1

Sales & asset price81

Price/Sales74

EV / Gross Profit94

Price/Book76

Quality70

Returns on capital89

Return on Capital82

Cash Return on Capital97

Return on Equity87

Profit margins76

EBIT Margin64

Gross Profitability88

Cash backing61

Accruals31

Owner Earnings Margin91

Growth—

Sales growth30

Profit growth1

Reinvestment100

Price momentum99

Safety22

Debt load71

Debt serviceability25

Refinancing48

Debt Payback1

Liquidity1

Sentiment64

Analyst ratings—

Expectations trend—

Market mood1

Value Creation4/20not creating value

Creates more value than its capital costs
Owner earnings growing
Owner earnings per share growing
Reinvests at strong returns
Solid earnings base

What this means

Burning Rock Biotech doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryBritish Virgin Islands

IndustryBiotechnology

SizeSmall

TypePublic Company

ExchangeNASDAQGM

Founded2014

Employees53

Websitebrbiotech.com

ISINUS12233L2060

Last UpdateApr 2, 2026

Indices

NASDAQ (USA)

Themes

Health DiagnosticsOncologyGeneticsImmunologyBiotechnologyHealth CareMedical

Description

Burning Rock Biotech Limited operates as next-generation sequencing (NGS)-based cancer therapy selection company in China. The company conducts its NGS-based products and services business primarily through the wholly-owned subsidiaries of the VIE,…

Analysis

Quality compounder

Burning Rock Biotech Limited is a quality compounder: a well-run business trading at a price that reflects what it is worth. One caution: reported profits have recently run ahead of actual cash, which we track closely.

Valuation data is not available for this company.

The trajectory is mixed and the balance sheet is stretched. The company scores 4/20 on our value-creation score: not creating value. Analysts lean positive.

What to watch: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250

2026

All-time high

Jun 2026

All-time low

Mar 2026

Average rank

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

—

Price/Earnings

—

Price/Book

—

Dividend Yield

—

Value (overall)

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Burning Rock Biotech with its peers

Chularat Hospital

SET:CHG

CountryThailand